Intra-Cranial Hematoma as a First Manifestation of Brain Tumours, a Meta-Analysis

Introduction

Brain tumors and spontaneous intracerebral hemorrhage (ICH) are two distinct neurological conditions with overlapping clinical features and significant implications for patient management [1]. ICH is a type of stroke that results from the rupture of blood vessels within the brain parenchyma, leading to the formation of a hematoma and subsequent edema, mass effect, and neurologic dysfunction. Spontaneous ICH refers to bleeding that occurs in the absence of a clear precipitating factor, such as head trauma, vascular malformation, or anticoagulant use. Brain tumors are neoplastic growths arising from the brain parenchyma or surrounding structures, with varying histologic and molecular characteristics and potential for malignant transformation [2]. As these tumors grow, they can cause elevated intracranial pressure, cerebral edema, and local tissue damage, leading to a range of neurologic signs and symptoms [3]. The relationship between brain tumors and spontaneous ICH is complex and bidirectional [4]. On one hand, patients with brain tumors are at increased risk of developing spontaneous ICH, likely due to the presence of fragile and leaky blood vessels within the tumor microenvironment, as well as the use of anticoagulant or antiplatelet medications to manage symptoms such as seizures or thromboembolism [5]. In addition, the disruption of the blood-brain barrier and the activation of coagulation pathways by tumor cells or inflammatory mediators can further increase the risk of bleeding events [6]. On the other hand, spontaneous ICH can also be a presenting sign of an underlying brain tumor, particularly in cases of deep or lobar hemorrhage, younger age, and absence of vascular risk factors [7]. In these situations, neuroimaging studies such as computed tomography (CT) or magnetic resonance imaging (MRI) may reveal a mass lesion or tumor-related vasculopathy as the underlying cause of the bleeding [8]. The recognition of the relationship between brain tumors and spontaneous ICH is critical for accurate diagnosis, appropriate treatment, and improved outcomes. The management of these conditions may involve a multidisciplinary approach, including neurosurgery, radiation therapy, chemotherapy, and supportive care, depending on the tumor type, location, and grade, as well as the severity and evolution of the ICH. Early detection, risk stratification, and individualized treatment planning are essential to minimize morbidity and mortality in these complex and challenging scenarios.

Discussion

ICH has been found in about 10% of cases with BTs, while different clinicopathologic series have indicated that 0.8%–7.4% of BTs are associated with spontaneous ICH [9]. The occurrence of a hemorrhagic presentation in a previously silent BT is even more uncommon, and there is limited current evidence on this topic.

According to Burth s, findings, 33% of intratumoral bleeding originates from GBMs, with metastases, anaplastic gliomas, low-grade gliomas, meningiomas, adenomas, hemangioblastomas, melanomas, neuroblastomas, and pinealoblastomas contributing to varying extents [10]. In a study conducted by Kondziolka et al., it was observed that among 264 GBM cases, about 6.4% displayed macroscopic hemorrhage, while 12.9% exhibited microscopic hemorrhage [11]. An interesting case involves a GBM mimicking acute cerebral hemorrhage. In this particular instance, the hemorrhage took on a mixed type, primarily presenting as macroscopic hemorrhage [12]. In scientific literature, instances of hemorrhaging tumors with varying histologies have been documented. The most commonly observed bleeding tumors are metastases, particularly from melanoma, and malignant gliomas [13]. While glioblastoma demonstrates the highest overall incidence of bleeding tumors, primary melanoma and neuroblastoma, though comparatively rarer, exhibit a significantly higher bleeding ratio [14]. The frequency of bleeding escalates with the malignancy level of the tumor [15]. Noteworthy bleeding rates have been emphasized by some authors in anaplastic astrocytomas, oligodendrogliomas, and oligoastrocytomas, particularly in the context of intratumoral microhemorrhages [16]. These microhemorrhages are reported with comparable incidences in WHO grade IV astrocytomas (56%) and WHO grade III oligodendrogliomas(53%) [13]. Moreover, intratumoral bleeding within glioblastoma multiforme (GBM) may manifest when the tumor infiltrates sizable blood vessels, leading to the debilitation and disintegration of their walls [17]. Low-grade gliomas constitute approximately 15% of adult brain tumors. Despite a comparatively favorable prognosis compared to higher- grade glial tumors, 50% to 75% of patients with low-grade gliomas eventually succumb to their condition [18].

The current research indicates that 2.9% of surgical patients had previously undetected brain tumors causing acute intracerebral hemorrhage, a percentage consistent with previous findings for these types of tumors [19]. Metabolic studies failed to provide insights into the nature of the described lesion. However, hypometabolic PET images allowed us to await improvements in the patient’s neurological condition. Subsequent late MRI findings suggested an acute hemorrhagic event within the tumor. Despite its rarity, the initial misdiagnosis as a hemorrhagic cavernoma led to the partial removal of the tumor [20].

The reasons behind bleeding in low-grade gliomas remain unclear, as neither tumor necrosis nor abnormal vessels are typically present [21]. Some authors propose that abnormal vessels or endothelial proliferation could be the underlying cause of hemorrhage in oligodendrogliomas [22]. The literatures include descriptions of bleeding tumors for both low-grade astrocytic and oligodendroglial tumors, with instances of glioneuronal and pilocytic tumors also reported [23]. Although low-grade astrocytoma is not commonly associated with intracerebral hemorrhage, awareness of the potential hemorrhagic presentation is crucial for accurate diagnosis and proper management, including considerations for surgical timing and approach [24]. Remarkably, investigation has brought to light a previously unexamined connection between the hemorrhage type and the specific tumor type. Intriguingly, the findings indicate that High-Grade Gliomas and Metastatic Brain Tumors primarily instigate Hemorrhagic Contusions, while Low-Grade Gliomas are more commonly linked to Extra-Intratumoral Hemorrhages [25]. Contemporary literature underscores the varied biological characteristics displayed by both Low-Grade and High-Grade Gliomas, contingent upon their genetic subtypes, contributing to survival predictions. Current perspectives suggest that this genetic information may also influence the angiogenic processes in Low-Grade Gliomas [26]. Despite High-Grade Gliomas exhibiting heightened vascularization and more prevalent angiogenesis compared to Low-Grade Gliomas, the significance of microvascular proliferation characteristics has gained prominence in the grading and subtype classification of Low-Grade Gliomas [26]. It is widely recognized that Low-Grade Gliomas typically present ill-defined margins in areas of diffuse infiltration. Although constructing a robust hypothesis based on our existing knowledge remains a challenging task, we posit that the diffuse infiltrative nature of Low-Grade Gliomas, along with their poorly defined margins and the presence of feeble tumor-associated vessels inadequately supported by the surrounding glial tissue, may account for their tendency to induce Extra-Intratumoral Hemorrhages upon bleeding [27].

Conclusion

In summary, the intricate relationship between brain tumors and intracerebral hemorrhages (ICH) unfolds with nuanced complexities. While glioblastoma multiforme (GBM) exhibits a higher incidence of bleeding, metastases, anaplastic gliomas, and various tumor types contribute to the spectrum of hemorrhagic presentations. The study emphasizes the rarity of hemorrhagic events within low- grade gliomas, challenging our understanding of their etiology. Noteworthy symptoms, including sudden headache, nausea, vomiting, alterations in consciousness, and seizures, accompany these events, often appearing without warning. Radiologically identifying brain tumors amid severe bleeding poses a diagnostic challenge, necessitating comprehensive imaging and clinical evaluation. The novel exploration of the correlation between hemorrhage types and specific tumor types unveils a previously unexamined connection, shedding light on the intricate interplay between tumor biology, genetic subtypes, and the nature of hemorrhages. This research contributes crucial insights, emphasizing the need for heightened awareness, accurate diagnosis, and tailored management strategies in the realm of neuro-oncology.